JMJ FinTech Limited: Approves ₹1.6 Crore Preferential Issue and ₹2 Crore NCD Issue

JMJ FinTech Limited’s Board of Directors has approved a preferential issue of up to 16,00,000 equity shares, aggregating up to ₹1.6 crore, at a face value of ₹10 each. Additionally, the company will issue Secured, Unlisted, Redeemable Non-Convertible Debentures (NCDs) worth up to ₹2 crore on a private placement basis. These decisions aim to strengthen the company’s capital base and fund its growth initiatives.

Major Funding Approvals by JMJ FinTech

At its board meeting held on August 10, 2026, JMJ FinTech Limited announced several key financial and strategic approvals, including a preferential issue of equity shares and the issuance of Non-Convertible Debentures (NCDs). These measures are designed to enhance the company’s capital structure and provide necessary funding for future operations and expansion.

Preferential Issue of Equity Shares

The Board has approved a proposal to create, offer, issue, and allot up to 16,00,000 (Sixteen Lakhs) Equity Shares of face value ₹10/- each on a preferential basis. This issuance will be conducted in accordance with Chapter V of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The issue price and floor price will be determined based on a valuation report from a registered valuer. The company is also seeking in-principle approval from the Stock Exchange for this preferential issue.

Issuance of Non-Convertible Debentures (NCDs)

In a significant move to bolster its debt funding, JMJ FinTech Limited will issue Secured, Unlisted, Redeemable Non-Convertible Debentures (NCDs) aggregating up to ₹2,00,00,000/- (Rupees Two Crores only). This issuance will be conducted on a private placement basis. The Board has approved the core terms and conditions, the draft Private Placement Offer Letter (Form PAS-4), the opening of an Escrow Account, and the execution of necessary agreements. The NCDs carry interest rates of 12.00% & 12.50% and have a subscription period from September 1, 2026, to September 30, 2026, with a deemed date of allotment on October 1, 2026. IDBI Trusteeship Services Limited has been appointed as the Debenture Trustee for this issue.

Unaudited Financial Results

The Board also approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026. These results were reviewed and recommended by the Audit Committee.

Other Key Approvals

Further approvals include the appointment of a dedicated bank account for the preferential issue, the appointment of CA S Dehaleesan as an IBBI Registered Valuer for the equity share valuation, and the authorization of banking operations. A Building Construction Committee has also been constituted to oversee infrastructure activities.

Source: BSE

Previous Article

Lupin: US FDA Approves Generic Sodium Zirconium Cyclosilicate for Hyperkalemia

Next Article

Wockhardt: Launches Initiative to Combat Antimicrobial Resistance